Brighton Jones LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $974K | Buy |
14,106
+343
| +2% | +$23.7K | 0.03% | 331 |
|
|
2025
Q1 | $956K | Sell |
13,763
-374
| -3% | -$26K | 0.03% | 271 |
|
|
2024
Q4 | $1.22M | Sell |
14,137
-1,039
| -7% | -$89.4K | 0.04% | 227 |
|
|
2024
Q3 | $1.81M | Buy |
15,176
+606
| +4% | +$72.2K | 0.07% | 143 |
|
|
2024
Q2 | $2.08M | Buy |
14,570
+5,625
| +63% | +$803K | 0.07% | 148 |
|
|
2024
Q1 | $1.15M | Buy |
8,945
+1,134
| +15% | +$146K | 0.04% | 204 |
|
|
2023
Q4 | $808K | Buy |
7,811
+501
| +7% | +$51.8K | 0.03% | 236 |
|
|
2023
Q3 | $665K | Buy |
7,310
+1,500
| +26% | +$136K | 0.03% | 237 |
|
|
2023
Q2 | $470K | Buy |
5,810
+508
| +10% | +$41.1K | 0.02% | 306 |
|
|
2023
Q1 | $422K | Buy |
5,302
+66
| +1% | +$5.25K | 0.02% | 316 |
|
|
2022
Q4 | $354K | Sell |
5,236
-268
| -5% | -$18.1K | 0.02% | 302 |
|
|
2022
Q3 | $274K | Buy |
5,504
+848
| +18% | +$42.2K | 0.02% | 353 |
|
|
2022
Q2 | $259K | Buy |
4,656
+68
| +1% | +$3.78K | 0.02% | 360 |
|
|
2022
Q1 | $255K | Buy |
4,588
+74
| +2% | +$4.11K | 0.01% | 412 |
|
|
2021
Q4 | $253K | Buy |
+4,514
| New | +$253K | 0.01% | 425 |
|
|
2018
Q4 | – | Sell |
-10,060
| Closed | -$237K | – | 280 |
|
|
2018
Q3 | $237K | Buy |
+10,060
| New | +$237K | 0.03% | 238 |
|